219 related articles for article (PubMed ID: 34708030)
1. Advances and Opportunities of CRISPR/Cas Technology in Bioengineering Non-conventional Yeasts.
Shan L; Dai Z; Wang Q
Front Bioeng Biotechnol; 2021; 9():765396. PubMed ID: 34708030
[TBL] [Abstract][Full Text] [Related]
2. CRISPR-Cas Technology for Bioengineering Conventional and Non-Conventional Yeasts: Progress and New Challenges.
Xia Y; Li Y; Shen W; Yang H; Chen X
Int J Mol Sci; 2023 Oct; 24(20):. PubMed ID: 37894990
[TBL] [Abstract][Full Text] [Related]
3. Multiplex Genome Engineering Methods for Yeast Cell Factory Development.
Malcı K; Walls LE; Rios-Solis L
Front Bioeng Biotechnol; 2020; 8():589468. PubMed ID: 33195154
[TBL] [Abstract][Full Text] [Related]
4. Application of CRISPR/Cas System in the Metabolic Engineering of Small Molecules.
Singh R; Chandel S; Ghosh A; Dey D; Chakravarti R; Roy S; Ravichandiran V; Ghosh D
Mol Biotechnol; 2021 Jun; 63(6):459-476. PubMed ID: 33774733
[TBL] [Abstract][Full Text] [Related]
5. Recent advances in systems and synthetic biology approaches for developing novel cell-factories in non-conventional yeasts.
Patra P; Das M; Kundu P; Ghosh A
Biotechnol Adv; 2021; 47():107695. PubMed ID: 33465474
[TBL] [Abstract][Full Text] [Related]
6. Development and Application of CRISPR/Cas in Microbial Biotechnology.
Ding W; Zhang Y; Shi S
Front Bioeng Biotechnol; 2020; 8():711. PubMed ID: 32695770
[TBL] [Abstract][Full Text] [Related]
7. Road to the future of systems biotechnology: CRISPR-Cas-mediated metabolic engineering for recombinant protein production.
Roointan A; Morowvat MH
Biotechnol Genet Eng Rev; 2016; 32(1-2):74-91. PubMed ID: 28052722
[TBL] [Abstract][Full Text] [Related]
8. Genome editing systems across yeast species.
Yang Z; Blenner M
Curr Opin Biotechnol; 2020 Dec; 66():255-266. PubMed ID: 33011454
[TBL] [Abstract][Full Text] [Related]
9. CRISPeering: Bioengineering the Host Cells through CRISPRCas9 Genome Editing System as the Next-generation of Cell Factories.
Morowvat MH
Recent Pat Biotechnol; 2021 Oct; 15(2):137-147. PubMed ID: 33874877
[TBL] [Abstract][Full Text] [Related]
10. Recent trends in CRISPR-Cas system: genome, epigenome, and transcriptome editing and CRISPR delivery systems.
Bae T; Hur JW; Kim D; Hur JK
Genes Genomics; 2019 Aug; 41(8):871-877. PubMed ID: 31119685
[TBL] [Abstract][Full Text] [Related]
11. CRISPR-Cas9/CRISPRi tools for cell factory construction in E. coli.
Hashemi A
World J Microbiol Biotechnol; 2020 Jun; 36(7):96. PubMed ID: 32583135
[TBL] [Abstract][Full Text] [Related]
12. The CRISPR-Cas system for plant genome editing: advances and opportunities.
Kumar V; Jain M
J Exp Bot; 2015 Jan; 66(1):47-57. PubMed ID: 25371501
[TBL] [Abstract][Full Text] [Related]
13. [CRISPR/Cas-mediated DNA base editing technology and its application in biomedicine and agriculture].
Yu C; Mo J; Zhao X; Li G; Zhang X
Sheng Wu Gong Cheng Xue Bao; 2021 Sep; 37(9):3071-3087. PubMed ID: 34622618
[TBL] [Abstract][Full Text] [Related]
14. Exploiting endogenous CRISPR-Cas system for multiplex genome editing in Clostridium tyrobutyricum and engineer the strain for high-level butanol production.
Zhang J; Zong W; Hong W; Zhang ZT; Wang Y
Metab Eng; 2018 May; 47():49-59. PubMed ID: 29530750
[TBL] [Abstract][Full Text] [Related]
15. CRISPR-Cas9 System for Genome Engineering of Photosynthetic Microalgae.
Patel VK; Soni N; Prasad V; Sapre A; Dasgupta S; Bhadra B
Mol Biotechnol; 2019 Aug; 61(8):541-561. PubMed ID: 31140149
[TBL] [Abstract][Full Text] [Related]
16. CRISPR-based bioengineering in microalgae for production of industrially important biomolecules.
Dhokane D; Shaikh A; Yadav A; Giri N; Bandyopadhyay A; Dasgupta S; Bhadra B
Front Bioeng Biotechnol; 2023; 11():1267826. PubMed ID: 37965048
[TBL] [Abstract][Full Text] [Related]
17. Application of different types of CRISPR/Cas-based systems in bacteria.
Liu Z; Dong H; Cui Y; Cong L; Zhang D
Microb Cell Fact; 2020 Sep; 19(1):172. PubMed ID: 32883277
[TBL] [Abstract][Full Text] [Related]
18. Recent progress in CRISPR-based bioengineering of microbial cell factories for important nutraceuticals synthesis.
Hussain MI; Raziq A; Ahmed A; Iqbal MW; Tian R; Li J; Liu L; Liu Y
J Appl Microbiol; 2023 Jun; 134(6):. PubMed ID: 37279904
[TBL] [Abstract][Full Text] [Related]
19. CRISPR/Cas systems: opportunities and challenges for crop breeding.
Biswas S; Zhang D; Shi J
Plant Cell Rep; 2021 Jun; 40(6):979-998. PubMed ID: 33977326
[TBL] [Abstract][Full Text] [Related]
20. CRISPR/Cas: Advances, Limitations, and Applications for Precision Cancer Research.
Yang Y; Xu J; Ge S; Lai L
Front Med (Lausanne); 2021; 8():649896. PubMed ID: 33748164
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
